PITCH GUIDE

Medtech pitch deck guide

Clinical evidence drives commercial success

Medtech investors evaluate regulatory strategy, clinical evidence, and reimbursement pathways as seriously as market size. Your pitch must show a credible regulatory path, strong clinical data, and a realistic plan for how healthcare systems will pay for your technology.

46+ Medtech investors

Build your pitch deck

Key Metrics to Know

Clinical Outcome Improvement

Measurable improvement in patient outcomes vs. standard of care.

Benchmark: Peer-reviewed studies or controlled trials preferred; p < 0.05 required.

Regulatory Pathway and Timeline

FDA 510(k), De Novo, PMA, or CE marking status and expected approval date.

Benchmark: 510(k): 3-12 months, PMA: 2-4+ years, CE: 6-18 months.

Reimbursement Status

Existing CPT codes, proposed new codes, or payer coverage decisions.

Benchmark: Existing reimbursement dramatically de-risks commercial launch.

Cost per Procedure or Patient

All-in cost to deliver the technology to one patient.

Benchmark: Must compare favorably to current standard of care costs.

Hospital or Clinic Adoption Rate

Number of healthcare institutions using or trialing the technology.

Benchmark: Show key opinion leader endorsements and clinical site expansion.

Must-Have Slides

1Regulatory and clinical roadmap

Show a clear, credible path to market

State your regulatory class and submission strategy
Present existing clinical data and planned study endpoints
Identify your regulatory affairs lead by name

2Reimbursement strategy

Explain how healthcare systems will pay

Identify existing CPT codes or the pathway to new codes
Show payer coverage decisions or reimbursement rate benchmarks
Explain the hospital economic buyer decision process

3Commercial model

Show how you sell into healthcare systems

Name your distribution or sales strategy (direct, distributor, GPO)
Show pilot or commercial site pipeline with named institutions
Address physician adoption and training requirements

Common Mistakes to Avoid

!Underestimating regulatory timelines and associated costs
!No reimbursement strategy or assuming coverage will follow clearance
!Lacking clinical advisors or key opinion leader relationships
!Confusing CE marking with FDA clearance for US market entry
!Not including regulatory affairs expertise on the founding team

What investors expect

Clinical evidence from real patient populations, not bench testing alone
Named regulatory affairs expert and medical advisory board
Credible reimbursement strategy with economics for the payer
Key opinion leader endorsements and institutional pilot sites
Realistic capital plan covering regulatory, clinical, and commercial phases

Ready to pitch?

Use Pitchkit to create a professional medtech pitch deck with AI-powered feedback.

Create your pitch deck Browse 46 investors